NCT02508532 2022-06-21(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid TumorsBlueprint Medicines CorporationPhase 1 Completed250 enrolled 36 charts 2 FDA